Product
0.1% Hyaluronate
1 clinical trial
1 indication
Indication
Diabetic RetinopathyClinical trial
A Single Center, Randomized, Controlled Trial Comparing the Clinical Efficacy of 3% Diquafosol Tetrasodium and 0.1 % Hyaluronic Acid 0.1% in Diabetic Patients With Dry Eye DiseaseStatus: Not yet recruiting, Estimated PCD: 2023-12-01